BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 20093950)

  • 1. Capecitabine cardiac toxicity presenting as effort angina: a case report.
    Lestuzzi C; Crivellari D; Rigo F; Viel E; Meneguzzo N
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):700-3. PubMed ID: 20093950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report.
    Farina A; Malafronte C; Valsecchi MA; Achilli F
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):722-6. PubMed ID: 19584743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine may induce coronary artery vasospasm.
    Tsiamis E; Synetos A; Stefanadis C
    Hellenic J Cardiol; 2012; 53(4):320-3. PubMed ID: 22796820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capecitabine induced vasospastic angina.
    Coughlin S; Das S; Lee J; Cooper J
    Int J Cardiol; 2008 Oct; 130(1):e34-6. PubMed ID: 17897740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery spasm induced by capecitabine.
    Sestito A; Sgueglia GA; Pozzo C; Cassano A; Barone C; Crea F; Lanza GA
    J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):136-8. PubMed ID: 16645374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capecitabine-induced coronary vasospasm.
    Goldsmith YB; Roistacher N; Baum MS
    J Clin Oncol; 2008 Aug; 26(22):3802-4. PubMed ID: 18669470
    [No Abstract]   [Full Text] [Related]  

  • 7. Capecitabine cardiotoxicity--case reports and literature review.
    Manojlovic N; Babic D; Stojanovic S; Filipovic I; Radoje D
    Hepatogastroenterology; 2008; 55(85):1249-56. PubMed ID: 18795667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capecitabine-associated coronary vasospasm: a case report.
    Papadopoulos CA; Wilson H
    Emerg Med J; 2008 May; 25(5):307-9. PubMed ID: 18434478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial coronary artery spasm as cause of capecitabine-induced tako tsubo cardiomyopathy.
    Klag T; Cantara G; Ong P; Kaufmann M; Sechtem U; Athanasiadis A
    Clin Res Cardiol; 2014 Mar; 103(3):247-50. PubMed ID: 24276117
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina.
    Stewart T; Pavlakis N; Ward M
    Intern Med J; 2010 Apr; 40(4):303-7. PubMed ID: 20529041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary spasm induced by capecitabine.
    Schnetzler B; Popova N; Collao Lamb C; Sappino AP
    Ann Oncol; 2001 May; 12(5):723-4. PubMed ID: 11432636
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-Fluorouracil-induced vasospastic angina.
    Ayyildiz O; Karabulut A; Isikdogan A; Cakir O; Dursun M
    Ann Saudi Med; 2005; 25(3):263-5. PubMed ID: 16119534
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
    Rossi D; Alessandroni P; Catalano V; Giordani P; Fedeli SL; Fedeli A; Baldelli AM; Casadei V; Ceccolini M; Catalano G
    Clin Breast Cancer; 2007 Dec; 7(11):857-60. PubMed ID: 18269775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasospastic angina caused by 5-fluorouracil. A case report.
    Pop C; Nica R; Vlaicu R; Vinereanu D
    Rom J Intern Med; 2003; 41(4):433-7. PubMed ID: 15526525
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer chemotherapy and cardiovascular risks: is capecitabine-induced hypertriglyceridemia a rare adverse effect?
    Seminara P; Losanno T; Emiliani A; Manna G
    Cardiology; 2010; 116(1):42-4. PubMed ID: 20431291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capecitabine in breast cancer: the issue of cardiotoxicity during fluoropyrimidine treatment.
    Molteni LP; Rampinelli I; Cergnul M; Scaglietti U; Paino AM; Noonan DM; Bucci EO; Gottardi O; Albini A
    Breast J; 2010; 16 Suppl 1():S45-8. PubMed ID: 21050310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm.
    Shah NR; Shah A; Rather A
    J Oncol Pharm Pract; 2012 Mar; 18(1):132-5. PubMed ID: 21321041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of capecitabine-induced coronary microspasm in a patient with rectal cancer.
    Arbea L; Coma-Canella I; Martinez-Monge R; García-Foncillas J
    World J Gastroenterol; 2007 Apr; 13(14):2135-7. PubMed ID: 17465463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient.
    Aksoy S; Karaca B; Dinçer M; Yalçin S
    Ann Pharmacother; 2005 Mar; 39(3):573-4. PubMed ID: 15701780
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiotoxicity induced by 5-fluorouracil or capecitabine].
    Jensen SA; Baeksgaard L; Petersen LN; Reiter L; Sørensen JB
    Ugeskr Laeger; 2010 Jan; 172(1):48-51. PubMed ID: 20056096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.